# US 2017/0283366 A1 · Benzoquinone Derivatives For Treatment Of Cancer And Methods Of Making The Benzoquinone Derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283366 A1
- Document ID: US20170283366A1
- Status: Published application
- Kind: A1
- Application number: 15/090,457
- Filed: 2016-04-04
- Published: 2017-10-05
- Earliest claimed: 2016-04-04
- Applicants: United Arab Emirates University
- Inventors: Alaa Eldin Salem; Ibrahim Abdou; Ismail El Haty
- Web page: https://patentgrep.com/patent/US20170283366A1

## CPC

- C07D 207/06: with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07C 225/28: of non-condensed quinone rings
- C07D 295/13: to an acyclic saturated chain
- C07C 2601/08: the ring being saturated
- C07C 2601/16: the ring being unsaturated
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present invention benzoquinone derivatives of the formula (I): and to pharmaceutically acceptable salts or solvates thereof. In formula (I) one of X or Y is hydrogen and the other one of X or Y is 3-Trifluoro-methylaniline; 3,4,5-trifluoroaniline; 4-methoxylaniline; 4-fluoroaniline; 3,3′-Dimethyl-1,1′-Biphenyl-4,4′-diamine; 2-(pyrrolidin-l-yl)ethyl)amine; 4-trifluoromethyl-benzylamine ; 4-fluorobenzyl-amine; 3,4-dimethoxybenzylamine; or 3,5-ditrifluoromethyl-benzylamine. Compounds of formula (I) have been identified as being useful in the treatment of cancer, in particular lung, breast and pancreatic cancer. The invention relates also to a method of making the benzoquinone derivatives and to methods of treatment.

## Claims

### Claim 1

Compounds of formula (I):
or pharmaceutically acceptable salts or solvates thereof wherein:
one of X and Y is hydrogen and the other one of X and Y is selected from the group consisting of flouroaryl amines, biphenyl amines, amino-pyrrolidines and methoxyphenyl amines.

### Claim 2 (depends on 1)

The compounds of formula (I) as claimed in claim 1, or the pharmaceutically acceptable salts or solvates thereof, wherein said other one of X and Y is selected from the group consisting of 3-Trifluoro-methylaniline; 3,4,5-trifluoroaniline; 4-methoxylaniline; 4-fluoroaniline; 3,3′-Dimethyl-1,1′-Biphenyl-4,4′-diamine; 2-(pyrrolidin-1-yl)ethyl)amine; 4-trifluoromethyl-benzylamine ; 4-fluorobenzyl-amine ; 3,4-dimethoxybenzylamine and 3,5-ditrifluoromethyl-benzylamine.

### Claim 3 (depends on 1)

The compounds of formula (I) as claimed in claim 1, or the pharmaceutically acceptable salts or solvates thereof, wherein the compounds of formula (I) are selected from the group consisting of:
2,5-bis-(3-trifluoromethylanilino)-1,4-benzoquinone (BQ1);
2,5-bis-(3,4,5-trifluoroanilino)-1,4-benzoquinone (BQ2);
2,5-bis-(4-methoxylanilino)-1,4-benzoquinone (BQ3);
2,5-bis-(4-fluoroanilino)-1,4-benzoquinone (BQ4);
2,5-bis-((3,3′-Dimethyl-1,1′-Biphenyl-4-amine)-4′-amino)-1,4-benzoquinone (BQ6);
2,5-bis((2-(pyrrolidin-l-yl)ethyl)amino)-1,4-benzoquinone (BQ9);
2,5-bis-(4-trifluoromethylbenzylamino)-1,4-benzoquinone (BQ10);
2,5-bis-(4-fluorobenzylamino)-1,4-benzoquinone (BQ11);
2,5-bis-(3,4-dimethoxybenzylamino)-1,4-benzoquinone (BQ12); and
2,5-bis-(3,5-ditrifluoromethylbenzylamino)-1,4-benzoquinone (BQ14).

### Claim 4 (depends on 1)

A method of treating cancer in a mammal comprising administering to the mammal an amount of a compound of formula (I), as claimed in claim 1, or the pharmaceutically acceptable salts or solvates thereof.

### Claim 5 (depends on 4)

The method as claimed in claim 4, wherein the mammal is in need of cancer treatment.

### Claim 6 (depends on 4)

The method as claimed in claim 4, wherein the mammal is a human.

### Claim 7 (depends on 4)

The method as claimed in claim 4, wherein the method is for the treatment of pancreatic cancer, lung cancer, or breast cancer.

### Claim 8 (depends on 1)

A method of stabilizing G-quadruplex DNA that may be formed in a telomere region of a mammalian chromosome, the method comprising binding a compound of formula (I), as claimed in claim 1, or the pharmaceutically acceptable salts or solvates thereof, to the G-quadruplex DNA.

### Claim 9 (depends on 8)

The method as claimed in claim 8, wherein the mammalian chromosome is a human chromosome.

### Claim 10 (depends on 9)

The method as claimed in claim 9, wherein the human chromosome is from a human in need of cancer treatment.

### Claim 11 (depends on 10)

The method as claimed in claim 10, wherein the human is in need of cancer treatment for pancreatic cancer, lung cancer, or breast cancer.

### Claim 12 (depends on 1)

A method of inhibit telomerase enzyme in a mammalian cell, particularly a human cell, comprising administering to the cell an amount of a compound of formula (I), as claimed in claim 1, or the pharmaceutically acceptable salts or solvates thereof

### Claim 13 (depends on 12)

The method as claimed in claim 12, wherein the mammalian cell is from a mammal in need of cancer treatment.

### Claim 14 (depends on 13)

The method as claimed in claim 13, wherein the mammal is in need of cancer treatment for pancreatic cancer, lung cancer, or breast cancer.

### Claim 15 (depends on 12)

The method as claimed in claim 12, wherein the compound is administered in a therapeutically effective amount.

### Claim 16 (depends on 12)

The method as claimed in claim 12, wherein the method comprises binding the compound of formula (I), or the pharmaceutically acceptable salts, or solvates thereof, to G-quadruplex DNA that may be formed in the mammalian cell or in the human cell.
